78 filings
Page 4 of 4
8-K
yipel9p
29 Jul 19
Regulation FD Disclosure
4:40pm
8-K
94av22l
29 Jul 19
Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:40pm
8-K
kxw2xjt8hnvveri
25 Jul 19
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
4:01pm
8-K
dymnace4q4s16dp8vqx
21 Jun 19
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
g14pjt55fjz
23 May 19
Departure of Directors or Certain Officers
4:01pm
8-K
bqku7cckti n2
3 May 19
Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results
5:08pm
8-K
07vb0o osv8
28 Mar 19
Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development
4:00pm
8-K
uk1c6kgqz10
8 Mar 19
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
4:04pm
8-K
xkearl2 tq10bpc78
8 Jan 19
Regulation FD Disclosure
12:00am
8-K
052joucma5a5
9 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
4:14pm
8-K
5yfv6ear7w 4nrdx
9 Nov 18
Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results
12:40pm
8-K
9jjr9ehng3
9 Aug 18
Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
4:07pm
8-K
akdglv31gp uf5mn7gkj
11 Jun 18
Submission of Matters to a Vote of Security Holders
4:48pm
8-K
fwa6qsydmf
14 May 18
Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results
4:01pm
8-K
1oli2
2 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
kbb8qsfuh2nseg ipw
14 Mar 18
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
aa5ptn
1 Nov 17
Rhythm Announces Preliminary Data from Phase 2 Study of Setmelanotide for Treatment of
12:00am
8-K
own0ifyugjaly
10 Oct 17
Rhythm Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
12:00am